Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Pharmaceutical Factory (CZPHARM) is a prominent Chinese pharmaceutical manufacturer specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1949 and now a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., the company focuses on therapeutic areas including cardiovascular health, the central nervous system, and anti-infectives. CZPHARM is recognized for its high-quality manufacturing standards, holding certifications from the US FDA, EU GMP, and WHO for many of its products. The company is one of the world's largest producers of Captopril and Hydrochlorothiazide, maintaining a significant export presence in over 50 countries. With large-scale production facilities in Changzhou, the company serves as a critical supplier for both domestic and international healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Pharm.